Algeria vs Luxembourg: Cause of death, by non-communicable diseases, ages 60+, male
Algeria
80.5%
in 2021
Luxembourg
81.0%
in 2021
Algeria rank
39th
Luxembourg rank
36th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Algeria
- Luxembourg
How they compare
Luxembourg currently reports 81.0% against 80.5% in Algeria, a difference of 0.5%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Algeria ahead.
Algeria ranks 39th and Luxembourg ranks 36th of 185 countries.
Across the 3 decades both report, Algeria averaged higher in 2 and Luxembourg in 1.
Head to head by decade
| Decade | Algeria | Luxembourg | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.2% | 91.4% | 0.9% | Algeria |
| 2010s | 92.4% | 90.1% | 2.3% | Algeria |
| 2020s | 72.1% | 79.4% | 7.3% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Algeria or Luxembourg?
- Luxembourg, at 81.0% against 80.5% in Algeria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Algeria and Luxembourg?
- 0.5%, with Luxembourg ahead.
- How many years of comparable data are there for Algeria and Luxembourg?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Luxembourg rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Algeria ranks 39th and Luxembourg ranks 36th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.